OPDIVO® (nivolumab) OPDIVO® (nivolumab) is a prescription medication that treats certain types of cancer Read the indications, side effects, and more Please see Indication and Important Safety Information
Frequently Asked Questions (FAQ) | OPDIVO® (nivolumab) Find answers to frequently asked questions about OPDIVO® (nivolumab) including what OPDIVO® is, how immunotherapy works, and what are the side effects of OPDIVO®
OPDIVO® Support Patient Resources | OPDIVO® (nivolumab) Whether you're a new or continuing OPDIVO® (nivolumab) patient, find resources that can support you through a cancer diagnosis and during treatment Access helpful resources and find assistance for OPDIVO® patients here
Subcutaneous Injection Immunotherapy Treatment| OPDIVO Qvantig . . . Learn more about OPDIVO Qvantig™ (nivolumab+hyaluronidase-nvhy) as a subcutaneous injection immunotherapy treatment option for your fight against cancer Please see Indication and Important Safety Information
Clinical trial results for - OPDIVO See how OPDIVO® (nivolumab) + YERVOY® (ipilimumab) performed in a clinical trial as first-line treatment for adults with stage 4 or recurrent advanced non-small cell lung cancer that tested positive for PD-L1
Patient and Caregiver Stories | OPDIVO® (nivolumab) Watch videos of real OPDIVO® (nivolumab) patients and caregivers Learn more about patients' diagnoses and treatment experiences Please see Indication and Important Safety Information